Cargando…

Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia

Introduction: Genetic testing for familial hypercholesterolaemia (FH) is not yet established for widespread use internationally to provide diagnostic confirmation, in part due to high cost and resource requirement. We need to establish whether genetic testing is clinically justified in terms of risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Tina Z, Breen, Jane, Neves, Emma, Grocott-Mason, Richard, Barbir, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Magdi Yacoub Heart Foundation 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768534/ https://www.ncbi.nlm.nih.gov/pubmed/33426041 http://dx.doi.org/10.21542/gcsp.2020.24

Ejemplares similares

Evaluation of a novel rapid genomic test including polygenic risk scores for the diagnosis and management of familial hypercholesterolaemia
por: Neves, Emma, et al.
Publicado: (2021)

Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients
por: Surme, Serkan, et al.
Publicado: (2021)

Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
por: Blom, Dirk J., et al.
Publicado: (2018)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Incidental Risk of Type 2 Diabetes Mellitus among Patients with Confirmed and Unconfirmed Prediabetes
por: Brunisholz, Kimberly D., et al.
Publicado: (2016)

Nature's fifth force unconfirmed
por: CERN Press Office. Geneva
Publicado: (1965)

A few of our favorite unconfirmed ideas
por: Marini, John J, et al.
Publicado: (2015)

Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review
por: Mansilla-Rodríguez, María Elena, et al.
Publicado: (2023)

Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features
por: De Angelis, Giulia, et al.
Publicado: (2020)

Seven unconfirmed ideas to improve future ICU practice
por: Marini, John J., et al.
Publicado: (2017)

Prevalence and characteristics of anxiety in patients with unconfirmed pulmonary nodules
por: Wang, Xiao‐Hui, et al.
Publicado: (2023)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

Hypertriglyceridaemia: contemporary management of a neglected cardiovascular risk factor
por: Khan, Tina Z., et al.
Publicado: (2021)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
por: Pećin, Ivan, et al.
Publicado: (2017)

Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients
por: Mohammadnia, Niekbachsh, et al.
Publicado: (2022)

Pressed for Hard Facts: Multiple Tetrachloroethylene–Cancer Links Go Unconfirmed
por: Black, Harvey
Publicado: (2006)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
por: Capra, Maria Elena, et al.
Publicado: (2023)

Suspicion of mitochondrial disease remains frequently unconfirmed after whole exome sequencing
por: Finsterer, Josef, et al.
Publicado: (2018)

A perspective for sequencing familial hypercholesterolaemia in African Americans
por: Wright, Michelle L, et al.
Publicado: (2016)

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
por: Ramaswami, Uma, et al.
Publicado: (2017)

Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone
por: Diamond, David M, et al.
Publicado: (2021)

Reducing cardiovascular disease risk among families with familial hypercholesterolaemia by improving diet and physical activity: a randomised controlled feasibility trial
por: Kinnear, Fiona Jane, et al.
Publicado: (2020)

Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia
por: Correia, Marta, et al.
Publicado: (2021)

Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results
por: Deng, Xuelian, et al.
Publicado: (2022)

Hypercholesterolaemia in a vegan.
por: Duggan, B., et al.
Publicado: (1997)

Nutraceuticals in hypercholesterolaemia: an overview
por: Santini, Antonello, et al.
Publicado: (2016)

LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives
por: Al-Allaf, Faisal A, et al.
Publicado: (2010)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing
por: Maglio, C, et al.
Publicado: (2014)

Integration of child–parent screening and cascade testing for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2018)

Cholesterol Levels in Genetically Determined Familial Hypercholesterolaemia in Russian Karelia
por: Korneva, V. A., et al.
Publicado: (2017)

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care
por: Jones, Matthew, et al.
Publicado: (2022)

Improving detection and management of familial hypercholesterolaemia in Australian general practice
por: Brett, Tom, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_srpmo9d6ahunfbp78dc0eu19bp